P/B
0,3
IceCure Medical
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
$3.2M
Market Cap • 11/6/2026
2006
(20 years)
Founded
2013
(13 years ago)
IPO
NASDAQ
Listing Exchange
Israel
Country
Valuation
P/S
0,8
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
2,6
EPS
—
Market Cap
Market Cap
3,2M
EV
-8,8M
EV/Revenue
-2,2
EV/EBITDA
0,5
EV/EBIT
0,5
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-776,2%
Total Yield
-776,2%
Payout
0%
Retained Earnings
-129,2M
Profitability
Gross Margin
36,1%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
211,2%
Capex/Revenue
1,7%
Capex/D&A
24,3%
Capex/OCF
-0,4%
SBC/OCF
—
% PPE
5,7%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
-1,7%
CAGR Op. Income 5Y
20,8%
CAGR Net Income 5Y
22,2%
CAGR EPS 5Y
5,5%
CAGR OCF 5Y
19,5%
Leverage
N.D./EBITDA
0,7
Debt/Equity
0%
Current Ratio
2,9
Quick Ratio
2,1
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!